Extent of disease in recurrent prostate cancer determined by [Ga-68]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score

Frederik A. Verburg*, David Pfister, Axel Heidenreich, Andreas Vogg, Natascha I. Drude, Stefan Vöö, Felix M. Mottaghy, Florian F. Behrendt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)397-403
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue number3
Publication statusPublished - Mar 2016


  • PSA
  • PSA doubling time
  • Gleason score
  • Prostate cancer

Cite this